Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.94 USD | -3.49% | -19.04% | -50.02% |
Apr. 18 | Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating | MT |
Mar. 26 | 10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.02% | 3.45B | |
-1.04% | 12.47B | |
-17.29% | 6.99B | |
-2.21% | 5.1B | |
+2.66% | 4.27B | |
-4.79% | 4.27B | |
+7.65% | 2.61B | |
-15.92% | 2.08B | |
-3.53% | 1.67B | |
-13.66% | 1.48B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- Morgan Stanley Adjusts 10x Genomics' Price Target to $70 from $100, Keeps Overweight Rating